Phase I Scintigraphy Study of A Radiolabeled Solution of Ciclesonide Hydrofluroalkane Nasal Aerosol And A Radiolabeled Suspension of Ciclesonide Aqueous Nasal Spray in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2012
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Pharmacokinetics
- 28 Nov 2012 New trial record
- 12 Nov 2012 Results were presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), according to a Sunovion Pharmaceuticals media release.